Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. (SHE:002223)
China · Delayed Price · Currency is CNY 29.00
-0.57 (-1.93%)
May 14, 2026, 3:04 PM CST
SHE:002223 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 1,285 | 1,482 | 1,806 | 2,396 | 1,595 | 1,482 |
Depreciation & Amortization | 263.91 | 263.91 | 252.22 | 231.96 | 222.38 | 202.48 |
Other Amortization | 54.5 | 54.5 | 35.97 | 30.75 | 38.24 | 41.27 |
Loss (Gain) From Sale of Assets | -1.28 | -1.28 | -6.16 | -555.26 | -170.7 | -0.29 |
Asset Writedown & Restructuring Costs | 9.09 | 9.09 | 24.95 | 54.62 | 79.43 | 0.86 |
Loss (Gain) From Sale of Investments | -34.15 | -34.15 | -23.21 | -138.82 | -131.58 | -118 |
Provision & Write-off of Bad Debts | 3.76 | 3.76 | 20.87 | -9.49 | 12.66 | 27.08 |
Other Operating Activities | 127.57 | -8.26 | -20.5 | 74.3 | -38.13 | 52.77 |
Change in Accounts Receivable | 157.28 | 157.28 | -13.55 | 169.44 | 95.12 | 308.95 |
Change in Inventory | -56.78 | -56.78 | -23.74 | 62.71 | -259.43 | -302.81 |
Change in Accounts Payable | -358.67 | -358.67 | -101.09 | -375.6 | 853.77 | -471.42 |
Change in Other Net Operating Assets | -6.61 | -6.61 | 3.92 | -5.03 | 50.53 | - |
Operating Cash Flow | 1,442 | 1,503 | 1,816 | 2,127 | 2,305 | 1,201 |
Operating Cash Flow Growth | -19.80% | -17.25% | -14.61% | -7.72% | 91.88% | -57.57% |
Capital Expenditures | -126.12 | -128.98 | -128.43 | -132.57 | -379.37 | -284.32 |
Sale of Property, Plant & Equipment | 45.1 | 75.93 | 4.78 | 31.55 | 201.65 | 0.72 |
Cash Acquisitions | - | - | - | -17.08 | -81.54 | -318.37 |
Investment in Securities | -51.08 | -251.64 | 96.37 | 1,764 | -267.42 | -1,806 |
Other Investing Activities | -6,523 | -6,347 | 1.78 | 89.49 | 108.79 | 579.67 |
Investing Cash Flow | -6,655 | -6,652 | -25.5 | 1,735 | -417.89 | -1,829 |
Long-Term Debt Issued | - | - | - | 200 | 555.33 | 1,492 |
Total Debt Issued | - | - | - | 200 | 555.33 | 1,492 |
Long-Term Debt Repaid | - | -20.87 | -1,207 | -1,113 | -49.09 | -654.39 |
Total Debt Repaid | -20.87 | -20.87 | -1,207 | -1,113 | -49.09 | -654.39 |
Net Debt Issued (Repaid) | -20.87 | -20.87 | -1,207 | -913.36 | 506.24 | 837.79 |
Issuance of Common Stock | - | - | 7.61 | 99.6 | - | 149 |
Repurchase of Common Stock | - | - | - | - | -14.97 | -349.98 |
Common Dividends Paid | -799.01 | -799.01 | -1,224 | -660.58 | -350.81 | -318.85 |
Other Financing Activities | 0.73 | -1.94 | 25.06 | 9.16 | 214.43 | 456.74 |
Financing Cash Flow | -819.15 | -821.82 | -2,399 | -1,465 | 354.89 | 774.7 |
Foreign Exchange Rate Adjustments | -84.47 | -51.98 | 16.54 | 24.2 | 136.09 | -27.82 |
Net Cash Flow | -6,117 | -6,023 | -591.85 | 2,421 | 2,378 | 119.36 |
Free Cash Flow | 1,316 | 1,374 | 1,688 | 1,994 | 1,926 | 916.88 |
Free Cash Flow Growth | -20.75% | -18.60% | -15.37% | 3.58% | 110.01% | -57.39% |
Free Cash Flow Margin | 16.68% | 17.27% | 22.31% | 25.02% | 27.11% | 13.30% |
Free Cash Flow Per Share | 1.31 | 1.37 | 1.69 | 2.01 | 1.94 | 0.92 |
Cash Income Tax Paid | 580.55 | 608.33 | 622.82 | 904.42 | 497.29 | 448.59 |
Levered Free Cash Flow | -2,105 | 111.27 | 882.67 | 1,447 | 1,205 | 725.46 |
Unlevered Free Cash Flow | -2,101 | 115.02 | 895.63 | 1,484 | 1,241 | 744.52 |
Change in Working Capital | -266.43 | -266.43 | -273.57 | 43.06 | 697.58 | -487.39 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.